Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ibrahim Aldoss

Showing results (81-90 of 233) with videos related to

Pageof 24
Sort By:
American Journal of Hematology|January 24, 2023
Sequencing antigen-targeting antibodies and cellular therapies in adults with relapsed/refractory B-cell acute lymphoblastic leukemiaIbrahim Aldoss, Bijal D Shah, Jae H Park, et al.
Leukemia Research|February 7, 2018
Pegaspargase-related high-grade hepatotoxicity in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not predict recurrent hepatotoxicity with subsequent dosesPatrick W Burke, Ibrahim Aldoss, Matthew A Lunning, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 19, 2018
Rapid Acquisition of Cytomegalovirus-Specific T Cells with a Differentiated Phenotype, in Nonviremic Hematopoietic Stem Transplant Recipients Vaccinated with CMVPepVaxCorinna La Rosa, Jeffrey Longmate, Chetan Raj Lingaraju, et al.
American Journal of Hematology|May 12, 2017
Correlates of resistance and relapse during blinatumomab therapy for relapsed/refractory acute lymphoblastic leukemiaIbrahim Aldoss, Joo Song, Tracey Stiller, et al.
Blood Advances|January 24, 2025
Clinical use of measurable residual disease in adult ALL: recommendations from a panel of US expertsNicholas J Short, Ibrahim Aldoss, Daniel J DeAngelo, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 23, 2020
Characteristics and Trends of Adult Acute Lymphoblastic Leukemia in a Large, Public Safety-Net HospitalRohan Gupta, Tamer Othman, An Uche, et al.
Leukemia|July 21, 2018
Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myelomaIbrahim Aldoss, Marzia Capelletti, Jihye Park, et al.
Cancer Medicine|April 25, 2019
Combination chemotherapy plus dasatinib leads to comparable overall survival and relapse-free survival rates as allogeneic hematopoietic stem cell transplantation in Philadelphia positive acute lymphoblastic leukemiaJeremy Chang, Dan Douer, Ibrahim Aldoss, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 2, 2019
Post-Allogeneic Hematopoietic Stem Cell Transplantation Eculizumab as Prophylaxis Against Hemolysis and Thrombosis for Patients with Hematologic Disorders Associated with Paroxysmal Nocturnal Hemoglobinuria ClonesMatthew Mei, Rohan Gupta, Margaret O'Donnell, et al.
British Journal of Haematology|August 24, 2019
Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemiaIbrahim Aldoss, Jianying Zhang, Raju Pillai, et al.
Pageof 24

Showing results (81-90 of 233) with videos related to

Sort By:
Pageof 24
American Journal of Hematology|January 24, 2023
Sequencing antigen-targeting antibodies and cellular therapies in adults with relapsed/refractory B-cell acute lymphoblastic leukemiaIbrahim Aldoss, Bijal D Shah, Jae H Park, et al.
Leukemia Research|February 7, 2018
Pegaspargase-related high-grade hepatotoxicity in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not predict recurrent hepatotoxicity with subsequent dosesPatrick W Burke, Ibrahim Aldoss, Matthew A Lunning, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 19, 2018
Rapid Acquisition of Cytomegalovirus-Specific T Cells with a Differentiated Phenotype, in Nonviremic Hematopoietic Stem Transplant Recipients Vaccinated with CMVPepVaxCorinna La Rosa, Jeffrey Longmate, Chetan Raj Lingaraju, et al.
American Journal of Hematology|May 12, 2017
Correlates of resistance and relapse during blinatumomab therapy for relapsed/refractory acute lymphoblastic leukemiaIbrahim Aldoss, Joo Song, Tracey Stiller, et al.
Blood Advances|January 24, 2025
Clinical use of measurable residual disease in adult ALL: recommendations from a panel of US expertsNicholas J Short, Ibrahim Aldoss, Daniel J DeAngelo, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 23, 2020
Characteristics and Trends of Adult Acute Lymphoblastic Leukemia in a Large, Public Safety-Net HospitalRohan Gupta, Tamer Othman, An Uche, et al.
Leukemia|July 21, 2018
Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myelomaIbrahim Aldoss, Marzia Capelletti, Jihye Park, et al.
Cancer Medicine|April 25, 2019
Combination chemotherapy plus dasatinib leads to comparable overall survival and relapse-free survival rates as allogeneic hematopoietic stem cell transplantation in Philadelphia positive acute lymphoblastic leukemiaJeremy Chang, Dan Douer, Ibrahim Aldoss, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 2, 2019
Post-Allogeneic Hematopoietic Stem Cell Transplantation Eculizumab as Prophylaxis Against Hemolysis and Thrombosis for Patients with Hematologic Disorders Associated with Paroxysmal Nocturnal Hemoglobinuria ClonesMatthew Mei, Rohan Gupta, Margaret O'Donnell, et al.
British Journal of Haematology|August 24, 2019
Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemiaIbrahim Aldoss, Jianying Zhang, Raju Pillai, et al.
Pageof 24